News Archive
Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.
Six years from now, when my daughter turns 11, she will get a three-part human papillomavirus vaccine that will reduce her chances of getting cervical cancer by around 70 percent.
The Tongue Display Unit (TDU) can activate areas that are normally reserved for visual information and are unused when someone suffers from congenital blindness.
A pioneering new breast cancer research unit set up by leading UK charity Breakthrough Breast Cancer and the University of Edinburgh will be officially opened on Thursday 5 June 2008 by HRH The Prince of Wales (also known as The Duke of Rothesay while travelling in Scotland), the charity's Patron.
Pharmacological therapy combined with a rehabilitation program that teaches how to compensate for memory and attention problems offers new hope for people who suffer the consequences of traumatic brain injury.
› Verified 5 days ago